Stryker (SYK) Liabilities and Shareholders Equity (2009 - 2026)
Stryker (SYK) reported Liabilities and Shareholders Equity of $46.3 billion for Q1 2026, up 0.62% year-over-year from $46.0 billion in Q1 2025, and down 3.25% quarter-over-quarter from $47.8 billion in Q4 2025.
Stryker (SYK) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
Stryker (SYK) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $46.3 billion in Q1 2026.
- Liabilities and Shareholders Equity for Q1 2026 came in at $46.3 billion, up 0.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $187.5 billion (up 9.06% YoY), and the FY2025 annual result was $47.8 billion, up 11.34% from the prior year.
- Liabilities and Shareholders Equity declined to $46.3 billion in Q1 2026 per SYK's latest filing, from $47.8 billion in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $47.8 billion in Q4 2025 and troughed at $36.0 billion in Q3 2022.
- A 5-year average of $40.9 billion and a median of $39.4 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2025 and 2026: Liabilities and Shareholders Equity gained 18.4% in 2025, then grew 0.62% in 2026.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $36.9 billion in 2022, then climbed by 8.21% to $39.9 billion in 2023, then advanced by 7.66% to $43.0 billion in 2024, then gained by 11.34% to $47.8 billion in 2025, then declined by 3.25% to $46.3 billion in 2026.
- Business Quant data shows SYK's Liabilities and Shareholders Equity at $46.3 billion in Q1 2026, $47.8 billion in Q4 2025, and $47.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 22.72 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.29 Bn |
| Dec 31, 2025 | 47.84 Bn |
| Sep 30, 2025 | 47.06 Bn |
| Jun 30, 2025 | 46.33 Bn |
| Mar 31, 2025 | 46.01 Bn |
| Dec 31, 2024 | 42.97 Bn |
| Sep 30, 2024 | 43.83 Bn |
| Jun 30, 2024 | 39.13 Bn |
| Mar 31, 2024 | 39.40 Bn |
| Dec 31, 2023 | 39.91 Bn |
| Sep 30, 2023 | 38.04 Bn |
| Jun 30, 2023 | 37.41 Bn |
| Mar 31, 2023 | 36.83 Bn |
| Dec 31, 2022 | 36.88 Bn |
| Sep 30, 2022 | 35.98 Bn |
| Jun 30, 2022 | 36.03 Bn |
| Mar 31, 2022 | 36.14 Bn |
| Dec 31, 2021 | 34.63 Bn |
| Sep 30, 2021 | 34.15 Bn |
| Jun 30, 2021 | 33.70 Bn |